DOCSLIB.ORG

United States Patent (19) 11 Patent Number: 6,110,678 Weisburg Et Al

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
United States Patent (19) 11 Patent Number: 6,110,678 Weisburg Et Al USOO6110678A United States Patent (19) 11 Patent Number: 6,110,678 Weisburg et al. (45) Date of Patent: Aug. 29, 2000 54 TWO-STEPHYBRDIZATION AND OTHER PUBLICATIONS CAPTURE OF A POLYNUCLEOTIDE Arnold et al., “ASSay Formats Involving (75) Inventors: William G. Weisburg; Jay H. Shaw; Arcidinium-Ester-Labeled DNA Probes’, Clinical Chemis Michael M. Becker; Mehrdad Majlessi, all of San Diego, Calif. try, 35(8):1588–1594 (1989). Iwen et al., “Evaluation of Nucleic Acid-Based Test (PACE 73) Assignee: Gen-Probe Incorporated, San Diego, 2C) for Simultaneous Detection of Chlamydia trachomatis Calif. and Neisseria gonorrhoeae", J. Clin. Microbiology, 33(10):2587-2591 (1995). Appl. No.: 09/070,998 Lund et al., “Assessment of Methods for Covalent Binding Filed: May 1, 1998 of Nucleic Acids to Magnetic Beads, Dynabeads.TM, and the Characteristics of the Bound Nucleic Acids in Hybridization Related U.S. Application Data Reactions”, nucleic Acids Research, 16(22):10861-10880 60 Provisional application No. 60/045,430, May 2, 1997. (1988). 51 Int. Cl." ........................... C12Q 1/68; CO7H 21/02; C07H 21/04; C12N 15/00 Moore et al., “Amplification of rRNA for Assessment of 52) U.S. Cl. ............................ 435/6; 536/23.1; 536/24.3; Treatment Response of Pulmonary Tuberculosis Patients 935/76; 935/77; 935/78 during Antimicrobial Therapy”, J. Clin. Microbiology, 58 Field of Search ..................... 435/6, 91.2, 536/23.1, 34(7): 1745–1749 (1996). 536/24.3; 935/76, 77, 78 Nelson et al., “Detection of all Single-Base Mismatches in Solution by Chemiluminescence”, Nucleic Acids Research, 56) References Cited 24(24):4998–5003 (1996). U.S. PATENT DOCUMENTS Nelson et al., “Simultaneous Detection of Multiple Nucleic 4,486,539 12/1984 Ranki et al.. Acid Targets in a Homogeneous Format, Biochemistry, 4,581,333 4/1986 Kourilsky et al.. 35(25):8429–8438 (1996). 4,683,195 7/1987 Mullis et al.. 4,751,177 6/1988 Stabinsky. Sambrook et al., Molecular Cloning A Laboratory 4,755,458 7/1988 Rabbani et al.. Manual, 2nd Ed., vol. 1, Chpt. 1, S1.90–1.91, “Plasmid 4,868,105 9/1989 Urdea et al.. Vectors'; and Chpt. 7, $7.37–7.57, “Extraction, Purification, 4,894,325 1/1990 Englehardt et al.. and Analysis of Messenger RNA from Eukaryotic Cells”. 5,112,734 5/1992 Kramer et al.. 5,124,246 6/1992 Urdea et al.. Sambrook et al., Molecular Cloning A Laboratory 5,130.238 7/1992 Malek et al.. Manual, 2nd Ed., vol. 2, Chpt. 9, $9.47-9.51, “Analysis and 5,200,314 4/1993 Urdea. Cloning of Eukaryotic Genomic DNA; Chpt. 10, 5,252,723 10/1993 Bhatt et al.. 5,273,882 12/1993 Snitman et al.. $10.2-10.70, “Preparation of Radiolabeled DNA and RNA 5,283,174 2/1994 Arnold, Jr. et al.. Probes'; and Chpt. 11, S11.47-11.57, “Synthetic Olignucle 5,288,609 2/1994 Englehardt et al.. otide Probes. 5,399,491 3/1995 Kacian et al.. 5,437,990 8/1995 Burg et al.. morrissey et al., Analytical Biochemistry 181 : 345-359 5,547,842 8/1996 Hogan et al.. (1989). 5,554,516 9/1996 Kacian et al.. 5,635,352 6/1997 Urdea et al. ................................ 435/6 5,656.207 8/1997 Woodhead et al.. Primary Examiner W. Gary Jones 5,658,737 8/1997 Nelson et al.. ASSistant Examiner Ethan Whisenant 5,702,896 12/1990 Collins et al. .............................. 435/6 Attorney, Agent, or Firm-Christine A. Gritzmacher; Carlos 5,731,148 3/1998 Becker et al.. A. Fisher 5,731,153 3/1998 Lucas et al.. 5,750,338 5/1998 Collins et al.. 57 ABSTRACT FOREIGN PATENT DOCUMENTS A method for capturing a target polynucleotide in a Sample 0159719 10/1985 European Pat. Off.. onto a Solid Support with an attached immobilized probe by 0265244 4/1988 European Pat. Off.. using a capture probe and two different hybridization 0328829 8/1989 European Pat. Off.. conditions, which preferably differ in temperature only, is 0370694 5/1990 European Pat. Off.. disclosed. The two hybridization conditions control the 0526912 2/1993 European Pat. Off.. order of hybridization, where the first hybridization condi 88O1302 2/1988 WIPO. tions allow hybridization of the capture probe to the target WO 89/10979 11/1989 WIPO. polynucleotide, and the Second hybridization conditions WO901.0716 9/1990 WIPO. allow hybridization of the capture probe to the immobilized WO 91/08307 6/1991 WIPO. probe. The method may be used to detect the presence of a 94.03472 2/1994 WIPO. target polynucleotide in a Sample by detecting the captured 9419023 9/1994 WIPO. 95.03430 2/1995 WIPO. target polynucleotide or amplified target polynucleotide. WO95/16055 6/1995 WIPO. 881.0315 12/1999 WIPO. 13 Claims, 4 Drawing Sheets U.S. Patent Aug. 29, 2000 Sheet 1 of 4 6,110,678 1 O 15 \ (a) ( (a) - , (e) FIG. 1A 1 O ? 2O N (a): -- to N-(a) F.G. 1B U.S. Patent Aug. 29, 2000 Sheet 2 of 4 6,110,678 22 1 O ) (A) Na A.F---. YP (-) A. (+) (c) S(a) | 23 (B) 24 - - - - - - - - - - - - - -op- - (+)O (C) (-) (D) --- $3 24 ! (E)E (+)(-) FIG. 2 U.S. Patent Aug. 29, 2000 Sheet 3 of 4 6,110,678 3O 10 35 31 33 1>(), - \ N(a) ? ( 34f -- 32 (c) N(a) (b) FIG. 3A 50 1 O 40 30 - ? \ N to v - Sof \ (c) '-(a) 34 (b) FIG. 3B 1 O 40 N (a) y (d)) / (a) 9 (b) FIG. 3C U.S. Patent Aug. 29, 2000 Sheet 4 of 4 6,110,678 (CI) (o) |8 ,G?VÝVOJLVOJLLVEÐJALOOVVJL£VOI?JLJLLVVVVVVVVVVVVVVÇ 18LLLLLLLLLLLLLL NINININININI*,G 18LLLLLLLLLLLLLL «»,«;•& • 18LLLLLLLLLLLLLL 0T 6,110,678 1 2 TWO-STEPHYBRIDIZATION AND labeled with Specific binding partners to immobilize primers CAPTURE OF A POLYNUCLEOTIDE and primer extension products. The label Specifically com plexes with its receptor which is bound to a Solid Support. RELATED APPLICATION SUMMARY OF THE INVENTION This application claims priority to U.S. Provisional Appli According to one aspect of the invention, there is dis cation No. 60/045,430, filed May 2, 1997, under 35 U.S.C. closed a method of capturing a target polynucleotide present S 119(e). in a Sample. The method includes the Steps of incubating a FIELD OF THE INVENTION mixture comprising a target polynucleotide, a capture probe, and an immobilized probe in a first hybridization condition The present invention relates to methods for capturing a that favors formation of a capture probe: target hybridization polynucleotide which may be present in a Sample onto a complex that includes the capture probe and the target Solid Support. The invention is particularly useful for Sepa polynucleotide, wherein the first hybridization condition rating a target polynucleotide from other material in a disfavors formation of an immobilized probe:capture probe Sample, and is preferably employed as part of a diagnostic 15 hybridization complex that includes the immobilized probe procedure to detect the presence of the target polynucleotide and the capture probe; and then incubating the mixture in a in a Sample. second hybridization condition that favors formation of the immobilized probe:capture probe hybridization complex, BACKGROUND OF THE INVENTION thereby capturing the target polynucleotide in an immobi A target polynucleotide is a polynucleotide present in a lized probe:capture probe: target hybridization complex that Sample that can be purified from one or more Sample includes the immobilized probe, the capture probe and the components and/or whose presence can be detected using target polynucleotide. In one embodiment, the first incubat different techniques. Such techniques are typically carried ing step uses a temperature below a T of the capture out as part of a diagnostic procedure to detect the presence probe: target hybridization complex and above a T of the of a target polynucleotide which is indicative of the presence 25 immobilization probe:capture probe hybridization complex, of an infectious agent or pathogenic condition. and the Second incubating Step uses a temperature below a The presence of a target polynucleotide base Sequence T of the immobilization probe:capture probe hybridization region, present in a target polynucleotide, can be detected by complex. Preferably, the Second incubating Step is achieved various methods Such as those using nucleic acid probes that by lowering the temperature of the first hybridization con hybridize to a target Sequence. Probes can be designed to dition by at least about 10 C., or by at least about 20° C. In detect different target Sequences Such as those characteristic one preferred embodiment the first incubating Step uses a of microorganisms, viruses, human genes, plant or animal temperature of about 60° C. and the Second incubating Step genes, and/or pathogenic conditions. uses a temperature of about 40 C. or lower. Alternatively, A technique for purifying a target polynucleotide, which the first incubating Step may use a Solution having a chemi is often used in diagnostic procedures, involves capturing a 35 cal Stringency that favors formation of the capture probe target polynucleotide onto a Solid Support. The Solid Support :target hybridization complex and disfavors formation of the retains the target polynucleotide during one or more Washing immobilization probe:capture probe hybridization complex, Steps of the target polynucleotide purification procedure. and the Second incubating Step lowers the chemical Strin Ranki et al., U.S. Pat. No. 4,486,539 describe a hybrid gency of the Solution, thereby favoring formation of the ization Sandwich technique for capturing and for detecting 40 immobilization probe:capture probe hybridization complex. the presence of a target polynucleotide. The technique One embodiment of the method also includes the step of involves the capture of the target polynucleotide by a probe purifying the immobilized probe:capture probe: target bound to a Solid Support and hybridization of a detection hybridization complex.
Load more

Recommended publications
  • Mirna Research Guide Mirna Guide Cover Final.Qxd 9/28/05 10:24 AM Page 4
    miRNA_guide_cover_final.qxd 9/28/05 10:24 AM Page 3 miRNA Research Guide miRNA_guide_cover_final.qxd 9/28/05 10:24 AM Page 4 Contents Introduction to microRNAs and Experimental Overview Introduction to microRNAs . .1 miRNA Experimental Overview . .2 microRNA Isolation and Enrichment miRNA Isolation . .3 mirVana™ miRNA Isolation Kits . .3 “miRNA Certified” FirstChoice® Total RNA . .3 RecoverAll™ Total Nucleic Acid Isolation Kit . .3 miRNA Enrichment . .4 flashPAGE™ Fractionator System . .4 Global microRNA Expression Profiling miRNA Expression Profiling . .5 Overview of the mirVana™ Array System . .6 mirVana™ miRNA Labeling Kit . .7 mirVana™ miRNA Probe Set . .7 mirVana™ miRNA Bioarrays . .8 Detection and Quantification of Specific microRNAs mirVana™ miRNA Detection Kit . .9 mirVana™ miRNA Probe and Market Kit . .9 mirVana™ miRNA Probe Construction Kit . .10 mirVana™ qRT-PCR miRNA Detection Kit . .11 microRNA Functional Analysis miRNA Functional Analysis . .12 Anti-miR™ miRNA Inhibitors . .12 Pre-miR™ miRNA Precursor Molecules . .13 siPORT™ NeoFX™ Transfection Agent . .13 pMIR-REPORT™ miRNA Expression Reporter Vector . .13 microRNA Information Resources miRNA Resource . .14 miRNA Database . .14 miRNA Array Resource . .14 Introduction to microRNAs . .14 miRNA Application Guide . .15 Technical miRNA Seminars . .15 Highly Trained miRNA Technical Support Scientists . .15 miRNA e-Updates . .15 TechNotes Newsletter . .15 Reference Relative miRNA Expression Among Common Cell Types . .16 miRNA_guide_guts_final.qxd 9/28/05 10:26 AM Page 1 Introduction to microRNAs and Experimental Overview Introduction to microRNAs Overview of microRNA processing Small regulators with global impact miRNAs are transcribed as regions of longer RNA molecules that can be as long as 1000 nt (Figure 3). Description of microRNAs MicroRNAs (miRNAs) are evolutionarily conserved, small, noncoding RNA mol- The longer RNA molecules are processed in the nucleus into hairpin RNAs of ecules that regulate gene expression at the level of translation (Figure 1).
    [Show full text]
  • Riboprobe(R) in Vitro Transcription Systems Technical Manual TM016
    TECHNICAL MANUAL Riboprobe® in vitro Transcription Systems InstrucƟ ons for use of Products P1420, P1430, P1440, P1450 and P1460 Revised 10/13 TM016 tm016.1013:EIVD_TM.qxd 9/26/2013 11:10 AM Page 1 Riboprobe® in vitro Transcription Systems All technical literature is available on the Internet at www.promega.com/protocols Please visit the web site to verify that you are using the most current version of this Technical Manual. Please contact Promega Technical Services if you have questions on use of this system. E-mail [email protected] 1. Description..........................................................................................................1 2. Product Components.........................................................................................3 3. General Considerations....................................................................................4 A. Properties of Promega Vectors Suitable for in vitro Transcription ..............4 B. Applications of Promega Vectors ......................................................................6 C. General Cloning Techniques ..............................................................................6 4. RNA Transcription in vitro .............................................................................7 A. DNA Template Preparation................................................................................7 B. Synthesis of High-Specific-Activity Radiolabeled RNA Probes ...................8 C. Determining Percent Incorporation and Probe Specific Activity ...............10
    [Show full text]
  • Mutation of a DNA Polymerase Into an Efficient RNA Polymerase
    Directed evolution of novel polymerase activities: Mutation of a DNA polymerase into an efficient RNA polymerase Gang Xia, Liangjing Chen, Takashi Sera, Ming Fa, Peter G. Schultz*, and Floyd E. Romesberg* Department of Chemistry, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037 Edited by Jack W. Szostak, Massachusetts General Hospital, Boston, MA, and approved March 22, 2002 (received for review October 30, 2001) The creation of novel enzymatic function is of great interest, but of an attached substrate. However, the substrate was attached to remains a challenge because of the large sequence space of the major phage coat protein, pVIII, raising the concern of proteins. We have developed an activity-based selection method to cross-reactivity between a polymerase on one phage and a evolve DNA polymerases with RNA polymerase activity. The Stoffel substrate attached to another phage. Cross-reactivity will com- fragment (SF) of Thermus aquaticus DNA polymerase I is displayed promise the association of genotype with phenotype and inhibit on a filamentous phage by fusing it to a pIII coat protein, and the the successful evolution of desired function (see below). substrate DNA template͞primer duplexes are attached to other We have developed an activity-based selection method, in which adjacent pIII coat proteins. Phage particles displaying SF poly- a DNA polymerase and its substrate are both attached to the minor merases, which are able to extend the attached oligonucleotide phage coat protein, pIII. The pIII proteins are localized to only one primer by incorporating ribonucleoside triphosphates and biotin- end of the phage particle (Fig.
    [Show full text]
  • Sequential Structures Provide Insights Into the Fidelity of RNA Replication
    Sequential structures provide insights into the fidelity of RNA replication Cristina Ferrer-Orta*, Armando Arias†, Rosa Pe´ rez-Luque*, Cristina Escarmi´s†, Esteban Domingo†, and Nuria Verdaguer*‡ *Institut de Biologia Molecular de Barcelona, Parc Cientı´ficde Barcelona, Josep Samitier 1-5, E-08028 Barcelona, Spain; and †Centro de Biologı´aMolecular ‘‘Severo Ochoa,’’ Cantoblanco, E-28049 Madrid, Spain Edited by Michael G. Rossmann, Purdue University, West Lafayette, IN, and approved April 16, 2007 (received for review February 6, 2007) RNA virus replication is an error-prone event caused by the low evidence of how the physiological substrates bind the large fidelity of viral RNA-dependent RNA polymerases. Replication exposed active site of the picornavirus RDRPs (12, 13). In fidelity can be decreased further by the use of mutagenic ribonu- addition, the structure of the complex between the polymerase cleoside analogs to a point where viral genetic information can no 3D and its protein–primer VPg revealed the critical interactions longer be maintained. For foot-and-mouth disease virus, the an- involved in the positioning and addition of the first nucleotide tiviral analogs ribavirin and 5-fluorouracil have been shown to be (UMP) to the primer molecule, providing insights into the mutagenic, contributing to virus extinction through lethal mu- mechanism of initiation of RNA genome replication in picor- tagenesis. Here, we report the x-ray structure of four elongation naviruses (14). complexes of foot-and-mouth disease virus polymerase 3D ob- Here, we report the crystallographic analysis of four catalytic tained in presence of natural substrates, ATP and UTP, or muta- complexes of FMDV 3D involving different nucleotides or genic nucleotides, ribavirin triphosphate and 5-fluorouridine mutagenic nucleotide analogs: 3D⅐GCAUGGGCCC⅐ATP, triphosphate with different RNAs as template–primer molecules.
    [Show full text]
  • Bringing RNA Into View: RNA and Its Roles in Biology. INSTITUTION Biological Sciences Curriculum Study, Colorado Springs
    DOCUMENT RESUME ED 468 800 SE 064 476 AUTHOR Atkins, John F.; Ellington, Andrew; Friedman, B. Ellen; Gesteland, Raymond F.; Noller, Harry F.; Pasquale, Stephen M.; Storey, Richard D.; Uhlenbeck, Olke C.; Weiner, Alan M. TITLE Bringing RNA into View: RNA and Its Roles in Biology. INSTITUTION Biological Sciences Curriculum Study, Colorado Springs. SPONS AGENCY National Science Foundation, Arlington, VA. PUB DATE 2000-00-00 NOTE 194p. CONTRACT NSF-9652921 AVAILABLE FROM BSCS, Pikes Peak Research Park, 5415 Mark Dabling Blvd., Colorado Springs, CO 80918-3842. Tel: 719-531-5550; Web site: http://www.bscs.org. PUB TYPE Guides Classroom Learner (051) Guides Classroom Teacher (052) EDRS PRICE EDRS Price MF01/PC08 Plus Postage. DESCRIPTORS *Science Activities; Biology; *Genetics; Higher Education; *Instructional Materials; *RNA; Science Instruction ABSTRACT This guide presents a module for college students on ribonucleic acid (RNA) and its role in biology. The module aims to integrate the latest research and its findings into college-level biology and provide an opportunity for students to understand biological processes. Four activities are presented: (1) "RNA Structure:- Tapes to Shapes"; (2) "RNA Catalysis"; (3) "RNA and Evolution"; and (4)"RNA Evolution in Health and Disease." (Contains 28 references.) (YDS) Reproductions supplied by EDRS are the best that can be made from the original document. 00 00 7I- r21 4-1 T COPYAVAILABL U S DEPARTMENT OF EDUCATION Office of Educational Research and Improvement PERMISSION TO REPRODUCE AND EDUCATIONAL RESOURCES INFORMATION DISSEMINATE THIS MATERIAL HAS CENTER (ERIC) BEEN GRANTED BY This document has been reproduced as received from the person or organization hating it.
    [Show full text]
  • Synthetic Bpnas As Allosteric Triggers of Hammerhead Ribozyme Catalysis
    Synthetic bPNAs as allosteric triggers of Hammerhead ribozyme catalysis Yufeng Liang, Jie Mao and Dennis Bong1 Department of Chemistry and Biochemistry, The Ohio State University, Columbus, OH 43210 1Corresponding author email address: [email protected] Contents 1. Introduction 2. Triggering RNA structure-function 3. Synthetic Protocols 3.1 Materials and instrumentation for chemical synthesis 3.2 Synthesis of bPNA amino acid derivatives 3.3 Solid phase synthesis of bPNAs 3.4 Oligoethyleneimine bPNAs from nucleophilic aromatic substitution 3.5 Oligoethyleneimine bPNAs from reductive alkylation 4. Design and preparation of U-site HHR constructs 4.1 Materials, instrumentation and general notes for transcription 4.2 Design of modified HHR transcripts with U-sites for allosteric binding 4.3 Design and use of stem/loop replacement HHR sequences 4.4 Design and use of U-loop replacement binary HHRs 5. Triggering HHR catalysis with bPNAs 5.1 General reaction protocols 5.2 Experimental design and optimizing conditions 6. Summary Acknowledgements References 1 Abstract The biochemistry and structural biology of the hammerhead ribozyme (HHR) has been well-elucidated. The secondary and tertiary structural elements that enable sugar-phosphate bond scission to be be catalyzed by this RNA are clearly understood. We have taken advantage of this knowledge base to test the extent to which synthetic molecules, may be used to trigger structure in secondary structure and tertiary interactions and thereby control HHR catalysis. These molecules belong to a family of molecules we call generally call “bPNAs” based on our work on bifacial peptide nucleic acid (bPNA). This family of molecules display the “bifacial” heterocycle melamine, which acts as a base-triple upon capturing two equivalents of thymine or uracil.
    [Show full text]
  • Evolutionary Dynamics in Molecular Populations of Ligase Ribozymes
    Portland State University PDXScholar Dissertations and Theses Dissertations and Theses 1-1-2010 Evolutionary Dynamics in Molecular Populations of Ligase Ribozymes Carolina Diaz Arenas Portland State University Follow this and additional works at: https://pdxscholar.library.pdx.edu/open_access_etds Let us know how access to this document benefits ou.y Recommended Citation Diaz Arenas, Carolina, "Evolutionary Dynamics in Molecular Populations of Ligase Ribozymes" (2010). Dissertations and Theses. Paper 44. https://doi.org/10.15760/etd.44 This Dissertation is brought to you for free and open access. It has been accepted for inclusion in Dissertations and Theses by an authorized administrator of PDXScholar. Please contact us if we can make this document more accessible: [email protected]. Evolutionary Dynamics in Molecular Populations of Ligase Ribozymes by Carolina Diaz Arenas A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy in Biology Dissertation Committee: Niles Lehman, Chair Susan Masta Suzanne Estes Kenneth Stedman James McNames Portland State University ©2010 Abstract The emergence of life depended on the ability of the first biopolymer populations to thrive and approach larger population sizes and longer sequences that could store enough information, as required for a cellular type of life. The evolution of these populations very likely occurred under circumstances under which Muller’s Ratchet in synergism with random drift could have caused large genetic deterioration of the biopolymers. The genetic deterioration of the molecules caused by the accumulation of mutations occurred during the copying process, can drive the populations to extinction unless there is a mechanism to counteract it.
    [Show full text]
  • Directed Polymerase Evolution ⇑ Tingjian Chen, Floyd E
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector FEBS Letters 588 (2014) 219–229 journal homepage: www.FEBSLetters.org Review Directed polymerase evolution ⇑ Tingjian Chen, Floyd E. Romesberg Department of Chemistry, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, United States article info abstract Article history: Polymerases evolved in nature to synthesize DNA and RNA, and they underlie the storage and flow of Received 19 October 2013 genetic information in all cells. The availability of these enzymes for use at the bench has driven a Revised 28 October 2013 revolution in biotechnology and medicinal research; however, polymerases did not evolve to func- Accepted 29 October 2013 tion efficiently under the conditions required for some applications and their high substrate fidelity Available online 5 November 2013 precludes their use for most applications that involve modified substrates. To circumvent these lim- Edited by Wilhelm Just itations, researchers have turned to directed evolution to tailor the properties and/or substrate rep- ertoire of polymerases for different applications, and several systems have been developed for this purpose. These systems draw on different methods of creating a pool of randomly mutated polymer- Keywords: Directed evolution ases and are differentiated by the process used to isolate the most fit members. A variety of polymer- Polymerase ases have been evolved, providing new or improved functionality, as well as interesting new insight Modified nucleotide into the factors governing activity. Protein engineering Ó 2013 Federation of European Biochemical Societies. Published by Elsevier B.V.
    [Show full text]
  • Nucleic Acids Research
    Volume 12 Number 18 1984 Nucleic Acids Research Functional messenger RNAs are produced by SP6 in vitro transcription of cloned cDNAs P.A.Krieg and D.A.Melton Department of Biochemistry and Molecular Biology, Harvard University, 7 Divinity Avenue, Cambridge, MA 02138, USA Received 27 June 1984; Revised and Accepted 7 September 1984 ABSTRACT We describe a method for the synthesis of microgram quantities of eu- caryotic messenger RNAs. Injection into the cytoplasn of frog oocytes and addition to wheat germ extracts show that these synthetic RNAs function ef- ficiently as messenger RNAs. We confirs that a 5' cap on the mRNA is essen- tial for translation in injected oocytes and show that most of the 3' flank- ing region, including the poly A tail, can be deleted without the abolition of protein synthesis. The method of mRNA synthesis involves in vitro tran- scription of cDNAs which have been cloned into SP6 vectors (described in the accompanying paper). This method enables one to produce large amounts of mRNA and consequently protein from any cDNA clone. INTRODUCTION In addition to serving as a template for translation, messenger RNAs are involved in several other cellular activities including transport from the nucleus (rev. in 1 and 2), attachment to the cytoskeleton (3), and lo- calization within the cytoplasm (4). The nature of the signals within messenger RNAs which may be important for these other activities are cer- tainly not understood. Indeed, many of these activities are themselves poorly characterized. One obvious approach to identifying and characteriz- ing RNA signals for mRNA transport or localization is to alter the sequence of the DRNA and test its activity.
    [Show full text]
  • Chapter 1: Cell-Free Packaging of Microrna Into Exosomes Reveals Y-Box Protein I As a Critical Sorting Factor
    UC Berkeley UC Berkeley Electronic Theses and Dissertations Title Mechanisms of RNA sorting into exosomes Permalink https://escholarship.org/uc/item/96v4155t Author Shurtleff, Matthew James Publication Date 2016 Peer reviewed|Thesis/dissertation eScholarship.org Powered by the California Digital Library University of California Mechanisms of RNA sorting into exosomes By Matthew James Shurtleff A dissertation submitted in partial satisfaction of the requirements for the degree of Doctor of Philosophy in Microbiology in the Graduate Division of the University of California, Berkeley Committee in charge: Professor Randy Schekman, Chair Professor Arash Komeili Professor James Hurley Professor Lin He Summer 2016 Abstract Mechanisms of RNA sorting into exosomes by Matthew James Shurtleff Doctor of Philosophy in Microbiology University of California, Berkeley Professor Randy Schekman, Chair Exosomes are vesicles that are released by cells into the extracellular environment and populate all bodily fluids. These vesicles contain molecular cargo, including RNA, proteins and lipids and therefore may serve as vehicles for intercellular communication by transferring unconventional signals between cells. Despite widespread scientific interest in the physiological role of exosomes in health and disease, little is currently known about how molecules are selectively sorted into exosomes. In the work described herein, I used biochemical approaches to purify exosomes from cells grown in culture and identify microRNAs that are selectively sorted into exosomes. I then developed a cell-free reaction that reconstitutes the selective sorting of microRNA into exosomes in vitro. The reaction was then utilized to identify an RNA binding protein, Y-box Protein I (YBX1), that is required for sorting an exosomal microRNA.
    [Show full text]
  • The Presence of Rntps Decreases the Speed of Mitochondrial DNA Replication Plos Genetics, 14(3): E1007315
    http://www.diva-portal.org This is the published version of a paper published in PLoS Genetics. Citation for the original published paper (version of record): Forslund, J M., Pfeiffer, A., Stojkovič, G., Wanrooij, P H., Wanrooij, S. (2018) The presence of rNTPs decreases the speed of mitochondrial DNA replication PLoS Genetics, 14(3): e1007315 https://doi.org/10.1371/journal.pgen.1007315 Access to the published version may require subscription. N.B. When citing this work, cite the original published paper. Permanent link to this version: http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-146802 RESEARCH ARTICLE The presence of rNTPs decreases the speed of mitochondrial DNA replication Josefin M. E. Forslund, Annika Pfeiffer☯, Gorazd Stojkovič☯, Paulina H. Wanrooij, Sjoerd Wanrooij* Department of Medical Biochemistry and Biophysics, Umeå University, Umeå, Sweden ☯ These authors contributed equally to this work. * [email protected] a1111111111 a1111111111 Abstract a1111111111 a1111111111 Ribonucleotides (rNMPs) are frequently incorporated during replication or repair by DNA a1111111111 polymerases and failure to remove them leads to instability of nuclear DNA (nDNA). Con- versely, rNMPs appear to be relatively well-tolerated in mitochondrial DNA (mtDNA), although the mechanisms behind the tolerance remain unclear. We here show that the human mitochondrial DNA polymerase gamma (Pol γ) bypasses single rNMPs with an OPEN ACCESS unprecedentedly high fidelity and efficiency. In addition, Pol γ exhibits a strikingly low fre- quency of rNMP incorporation, a property, which we find is independent of its exonuclease Citation: Forslund JME, Pfeiffer A, Stojkovič G, Wanrooij PH, Wanrooij S (2018) The presence of activity.
    [Show full text]
  • Small Molecules Exploiting Structural Differences Within Microrna-200 Precursors Family Members Reverse a Type 2 Diabetes Phenotype
    bioRxiv preprint doi: https://doi.org/10.1101/2020.06.27.175281; this version posted June 27, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Small molecules exploiting structural differences within microRNA-200 precursors family members reverse a type 2 diabetes phenotype Hafeez S. Haniffa,1, Xiaohui Liua,1, Laurent Knerrb, Malin Lemurellb, Daniel Abegga, Alexander Adibekiana, and Matthew D. Disneya,2 a The Scripps Research Institute, Department of Chemistry, 130 Scripps Way, Jupiter, FL 33458, USA b Medicinal Chemistry, Research and Early Development Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Pepparedsleden, 1, SE-431 83 Mölndal, Sweden 1 These authors contributed equally to this work. 2 Author to whom correspondence should be addressed Email: [email protected] Classification: Major: Biological Science; Minor: Biochemistry 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.06.27.175281; this version posted June 27, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Abstract MicroRNA families are pervasive in the human transcriptome, but specific targeting of individual members is a challenge because of sequence homology. Many of the secondary structures of the precursors to these miRs (pre-miRs), however, are quite different.
    [Show full text]